Saturday, 18 September 2021 05:20

CDC-led study ranks the 3 vaccines approved for use in US for effectiveness

Rate this item
(0 votes)

A head-to-head study of all three authorized coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer's in real-life use in keeping people out of the hospital, and Johnson & Johnson's Janssen vaccine comes in third, but still providing 71% protection.

Pfizer's vaccine provided 88% protection against hospitalization, and Moderna's was 93% effective.

The US Centers for Disease Control and Prevention led a nationwide study of vaccination involving more than 3,600 adults hospitalized for Covid-19 between March and August.

"Among U.S. adults without immunocompromising conditions, vaccine effectiveness against Covid-19 hospitalization during March 11--August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)," the team wrote in the CDC's weekly report on death and disease, the MMWR.

"Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

They found that the biggest difference between the vaccine made by Moderna and Pfizer/BioNtech's vaccine was driven by a decline that started about four months after people were fully vaccinated with Pfizer's vaccine.

"Differences in vaccine effectiveness between the Moderna and Pfizer-BioNTech vaccine might be due to higher mRNA content in the Moderna vaccine, differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna), or possible differences between groups that received each vaccine that were not accounted for in the analysis," the team wrote.

"A single dose of the Janssen viral vector vaccine had comparatively lower anti-SARS-CoV-2 antibody response and vaccine effectiveness against Covid-19 hospitalizations," they added.

"Understanding differences in vaccine effectiveness by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters. All FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

CDC worked with researchers across the country to study 3,689 patients at 21 hospitals in 18 states for the study. They also looked at antibodies in the blood of 100 healthy volunteers after they'd been vaccinated with one of the three available vaccines.

 

CNN

May 03, 2024

Passion, freedom and impact: The 3 ingredients of business success

More than 10 years ago I founded my then "small" business that today has more…
May 01, 2024

Overwhelming majority of Nigerians have lost confidence in INEC, survey reveals

Yiaga Africa, a prominent election observation group, reveals in its latest report that only 23…
April 27, 2024

Adults are sharing the things they are no longer interested in now that they're older

It's natural for our preferences to change as we get older. So when asked, "What…
April 13, 2024

A new camera can undress people almost in real time—to send a message about AI

Nuca, a new deepfake camera, is an art project that shows how artificial intelligence can…
May 03, 2024

Two military officers face court martial over drone strike that killed 85 civilians in Kaduna

Nigeria's military has ordered two officers to face court martial proceedings over a drone strike…
May 03, 2024

Here’s the latest as Israel-Hamas war enters Day 210

Here's what's on the table for Israel and Hamas in the latest cease-fire talks Israel…
May 01, 2024

Wellspring Consulting proposes cybersecurity investment to boost Nigeria's economy

In a bid to rescue Nigeria from its economic challenges, Wellspring Consulting advocates for significant…
April 30, 2024

Finidi George is new Head Coach for Super Eagles

Former Nigerian winger Finidi George has been appointed as the head coach of the national…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Prof Wale Are Olaitan: Editorial Consultant; Femi Kawonise: Head, Production & Administration; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2024 NewsScroll. All rights reserved.